MDS Virtual Congress 2021 Archives - Page 130 of 132

Ventilatory function and respiratory muscle strength in Parkinson’s disease at the early stage: observational study.

R. Gonçalves, N. de Souza, J. Barbosa Neto, C. Araújo, J. Veras, T. de Freitas, P. Cortez, C. Do Amaral, L. Cardoso, D. Dalles, E. Andrade (Manaus, Brazil)
Virtual reality for balance and mobility in Parkinson’s disease: systematic review and meta-analysis

E. Sarasso, A. Gardoni, A. Tettamanti, F. Agosta, M. Filippi, D. Corbetta (Milan, Italy)
Virtual Rehabilitation for Functional Movement Disorder

H. Bhatt, L. Macgillivray, K. Marcelle, S. Lidstone (Toronto, Canada)
Visual cognition differences between asymptomatic and symptomatic carriers of Huntington’s disease (HD)

M. Turuelo, MA. Acera, M. Diez-Cirarda, T. Fernández, B. Tijero, M. Carmona, M. Ruiz, J. Somme, J. Ruiz, A. Gabilondo, I. Croitoru, L. Pardina, N. Ayo, A. Murueta-Goyena, I. Gabilondo, JC. Gómez-Esteban, R. Del Pino (Barakaldo, Spain)
Visual Impairment along Parkinsonism Development and the Association to Non-vision dependent Cognitive Decline: A Prospective Nation-wide CLSA study

C. Yao, A. Szpindel, S. Fereshtehnejad, A. Pelletier, C. Wolfson, R. Postuma (Montréal, Canada)
Visualising tau in patients with progressive supranuclear palsy using PI2620-PET

L. Vivash, HM. Tang, K. Bertram, TJ. O'Brien (Melbourne, Australia)
Visualization Tool for DBS Programming with a Multiple Source, Constant Current System Reduces Initial Programming Time

J. Aldred, T. Zesiewicz, Y. Bezchlibnyk, J. Carlson, L. Chen, R. Jain (Spokane, USA)
Visuo-cognitive training in Parkinson’s disease: Protocol for a randomised cross-over trial.

J. Das, R. Morris, G. Barry, R. Walker, S. Stuart (Newcastle Upon Tyne, United Kingdom)
Vitamin D and Parkinson’s disease

D. Novotnyy (Novosibirsk, Russian Federation)
VMAT2 availability in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder

M. Valli, SS. Cho, C. Uribe, M. Masellis, R. Chen, A. Mihaescu, A. Strafella (Toronto, Canada)